Cargando…

Diabetes Prevalence in Sweden at Present and Projections for Year 2050

BACKGROUND: Data on the future diabetes burden in Scandinavia is limited. Our aim was to project the future burden of diabetes in Sweden by modelling data on incidence, prevalence, mortality, and demographic factors. METHOD: To project the future burden of diabetes we used information on the prevale...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Tomas, Ahlbom, Anders, Carlsson, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664416/
https://www.ncbi.nlm.nih.gov/pubmed/26619340
http://dx.doi.org/10.1371/journal.pone.0143084
_version_ 1782403420914712576
author Andersson, Tomas
Ahlbom, Anders
Carlsson, Sofia
author_facet Andersson, Tomas
Ahlbom, Anders
Carlsson, Sofia
author_sort Andersson, Tomas
collection PubMed
description BACKGROUND: Data on the future diabetes burden in Scandinavia is limited. Our aim was to project the future burden of diabetes in Sweden by modelling data on incidence, prevalence, mortality, and demographic factors. METHOD: To project the future burden of diabetes we used information on the prevalence of diabetes from the national drug prescription registry (adults ≥20 years), previously published data on relative mortality in people with diabetes, and population demographics and projections from Statistics Sweden. Alternative scenarios were created based on different assumptions regarding the future incidence of diabetes. RESULTS: Between 2007 and 2013 the prevalence of diabetes rose from 5.8 to 6.8% in Sweden but incidence remained constant at 4.4 per 1000 (2013). With constant incidence and continued improvement in relative survival, prevalence will increase to 10.4% by year 2050 and the number of afflicted individuals will increase to 940 000. Of this rise, 30% is accounted for by changes in the age structure of the population and 14% by improved relative survival in people with diabetes. A hypothesized 1% annual rise in incidence will result in a prevalence of 12.6% and 1 136 000 cases. Even with decreasing incidence at 1% per year, prevalence of diabetes will continue to increase. CONCLUSION: We can expect diabetes prevalence to rise substantially in Sweden over the next 35 years as a result of demographic changes and improved survival among people with diabetes. A dramatic reduction in incidence is required to prevent this development.
format Online
Article
Text
id pubmed-4664416
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46644162015-12-10 Diabetes Prevalence in Sweden at Present and Projections for Year 2050 Andersson, Tomas Ahlbom, Anders Carlsson, Sofia PLoS One Research Article BACKGROUND: Data on the future diabetes burden in Scandinavia is limited. Our aim was to project the future burden of diabetes in Sweden by modelling data on incidence, prevalence, mortality, and demographic factors. METHOD: To project the future burden of diabetes we used information on the prevalence of diabetes from the national drug prescription registry (adults ≥20 years), previously published data on relative mortality in people with diabetes, and population demographics and projections from Statistics Sweden. Alternative scenarios were created based on different assumptions regarding the future incidence of diabetes. RESULTS: Between 2007 and 2013 the prevalence of diabetes rose from 5.8 to 6.8% in Sweden but incidence remained constant at 4.4 per 1000 (2013). With constant incidence and continued improvement in relative survival, prevalence will increase to 10.4% by year 2050 and the number of afflicted individuals will increase to 940 000. Of this rise, 30% is accounted for by changes in the age structure of the population and 14% by improved relative survival in people with diabetes. A hypothesized 1% annual rise in incidence will result in a prevalence of 12.6% and 1 136 000 cases. Even with decreasing incidence at 1% per year, prevalence of diabetes will continue to increase. CONCLUSION: We can expect diabetes prevalence to rise substantially in Sweden over the next 35 years as a result of demographic changes and improved survival among people with diabetes. A dramatic reduction in incidence is required to prevent this development. Public Library of Science 2015-11-30 /pmc/articles/PMC4664416/ /pubmed/26619340 http://dx.doi.org/10.1371/journal.pone.0143084 Text en © 2015 Andersson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Andersson, Tomas
Ahlbom, Anders
Carlsson, Sofia
Diabetes Prevalence in Sweden at Present and Projections for Year 2050
title Diabetes Prevalence in Sweden at Present and Projections for Year 2050
title_full Diabetes Prevalence in Sweden at Present and Projections for Year 2050
title_fullStr Diabetes Prevalence in Sweden at Present and Projections for Year 2050
title_full_unstemmed Diabetes Prevalence in Sweden at Present and Projections for Year 2050
title_short Diabetes Prevalence in Sweden at Present and Projections for Year 2050
title_sort diabetes prevalence in sweden at present and projections for year 2050
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664416/
https://www.ncbi.nlm.nih.gov/pubmed/26619340
http://dx.doi.org/10.1371/journal.pone.0143084
work_keys_str_mv AT anderssontomas diabetesprevalenceinswedenatpresentandprojectionsforyear2050
AT ahlbomanders diabetesprevalenceinswedenatpresentandprojectionsforyear2050
AT carlssonsofia diabetesprevalenceinswedenatpresentandprojectionsforyear2050